|
gptkbp:instanceOf
|
gptkb:Controlled_substance_schedule
|
|
gptkbp:abusePotential
|
High
|
|
gptkbp:cannotBePrescribedBy
|
Telephone (except emergency)
|
|
gptkbp:cause
|
Severe psychological or physical dependence
|
|
gptkbp:definedIn
|
gptkb:21_U.S.C._§_812
|
|
gptkbp:example
|
gptkb:Cocaine
gptkb:Amphetamine
gptkb:Hydrocodone
gptkb:Hydromorphone
gptkb:Meperidine
gptkb:Methylphenidate
gptkb:Morphine
gptkb:Oxycodone
gptkb:Secobarbital
Methamphetamine
Fentanyl
|
|
gptkbp:hasAcceptedMedicalUse
|
Yes
|
|
gptkbp:notableFor
|
High risk of abuse and dependence
|
|
gptkbp:partOf
|
gptkb:Controlled_Substances_Act_(United_States)
|
|
gptkbp:prescriptionExpiration
|
Varies by state, often 6 months
|
|
gptkbp:prescriptionRequired
|
Yes
|
|
gptkbp:prescriptionType
|
Written or electronic only
|
|
gptkbp:recordKeepingRequired
|
Yes
|
|
gptkbp:refillsAllowed
|
No
|
|
gptkbp:regulates
|
gptkb:Drug_Enforcement_Administration
|
|
gptkbp:storage
|
Secure storage required
|
|
gptkbp:subject
|
State regulations
DEA quotas
|
|
gptkbp:transferRestrictions
|
No transfer between patients
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Schedule II drug (US)
|